awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50092012-24DC2086-31BF-4DED-8BE0-CAFB22E2F5B5
Q50092012-24DC2086-31BF-4DED-8BE0-CAFB22E2F5B5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50092012-24DC2086-31BF-4DED-8BE0-CAFB22E2F5B5
Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide.
P433
Q50092012-24DC2086-31BF-4DED-8BE0-CAFB22E2F5B5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50092012-24DC2086-31BF-4DED-8BE0-CAFB22E2F5B5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c7e189f6e5c953affcd546265b98c45eeed49715
P433
17
http://www.w3.org/2001/XMLSchema#string